SCHEMBL2637342

SCHEMBL2637342

COc1cc(C=Cc2ccc(S(C)(=O)=O)cc2)ccc1C=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 1/20 0.52
APP P05067 1/20 0.51
MAPT P10636 1/20 0.51
ALDH1A1 P00352 3/20 0.49
CYP1A1 P04798 5/20 0.46
CYP1B1 Q16678 5/20 0.46
CYP1A2 P05177 3/20 0.46
NFE2L2 Q16236 1/20 0.45
CA2 P00918 1/20 0.45
PTGS2 P35354 2/20 0.44
CYP19A1 P11511 1/20 0.44
TUBB4A P04350 1/20 0.44
TUBB P07437 1/20 0.44
TUBA3C P0DPH7 1/20 0.44
TUBA1B P68363 1/20 0.44
TUBA4A P68366 1/20 0.44
TUBB4B P68371 1/20 0.44
TUBB3 Q13509 1/20 0.44
TUBB2A Q13885 1/20 0.44
TUBB8 Q3ZCM7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2637340 1.00 ERN1 (0.52) ERN1APPMAPTALDH1A1CYP1A1
SCHEMBL2637738 0.85 CYP19A1 (0.62) APPMAPTCYP1A1CYP1B1CYP1A2
SCHEMBL2637736 0.85 CYP19A1 (0.62) APPMAPTCYP1A1CYP1B1CYP1A2
SCHEMBL4258547 0.84 CYP1A1 (0.62) APPMAPTALDH1A1CYP1A1CYP1B1
SCHEMBL4258548 0.84 CYP1A1 (0.62) APPMAPTALDH1A1CYP1A1CYP1B1
SCHEMBL10477813 0.84 ALDH1A1 (0.58) ERN1MAPTALDH1A1PTGS2SMN1; SMN2
SCHEMBL7090237 0.81 TUBB4A (0.51) MAPTALDH1A1CYP1A1CYP1B1CYP1A2
SCHEMBL13059995 0.80 MAPT (0.55) APPMAPTALDH1A1CYP1A1CYP1B1
SCHEMBL2637083 0.79 MAPT (0.51) APPMAPTALDH1A1CYP1A1CYP1B1
SCHEMBL2637081 0.79 MAPT (0.51) APPMAPTALDH1A1CYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2437792-B1 IMAGING OF MYELIN BASIC PROTEIN GEN ELECTRIC (US) 2015-10-21 EP disclosed
EP-2437792-A2 IMAGING OF MYELIN BASIC PROTEIN General Electric Company (US) 2012-04-11 EP disclosed
US-20100310456-A1 IMAGING OF MYELIN BASIC PROTEIN GENERAL ELECTRIC COMPANY (US) 2010-12-09 US disclosed
WO-2010141704-A2 IMAGING OF MYELIN BASIC PROTEIN GENERAL ELECTRIC COMPANY (US) 2010-12-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100310456-A1 IMAGING OF MYELIN BASIC PROTEIN MAG, PMP22, MYT1 ERN1 2631/4885APP 1205/4885MAPT 1129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.